Electrogastrography (EGC) in Premature Infants With Feeding Intolerance

Sponsor
National Center for Research Resources (NCRR) (NIH)
Overall Status
Completed
CT.gov ID
NCT00008736
Collaborator
Children's Hospital of Philadelphia (Other)
1

Study Details

Study Description

Brief Summary

Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Allocation:
Non-Randomized
Primary Purpose:
Treatment
Official Title:
Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Minute to 1 Month
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion:

    Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Hospital of Philadelphia Philadelphia Pennsylvania United States 19104

    Sponsors and Collaborators

    • National Center for Research Resources (NCRR)
    • Children's Hospital of Philadelphia

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00008736
    Other Study ID Numbers:
    • NCRR-M01RR00240-1724
    First Posted:
    Jan 18, 2001
    Last Update Posted:
    Jun 24, 2005
    Last Verified:
    Dec 1, 2003
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 24, 2005